BBLG Q2 2019 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2019 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$679,000

Net Income

-$926,000

EPS (Diluted)

$-18.47

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$13,548

Balance Sheet

Total Assets

$266,395

Total Liabilities

$11M

Stockholders' Equity

-$11M

Cash & Equivalents

$176,372

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$679,000	-$860,000	+21.0%
Net Income	-$926,000	-$1M	+26.7%